Universal Technical Institute Inc Dossier - Source-backed chat

Universal Technical Institute Inc

UTINYSE

SectorConsumer Staples

IndustryEducation & Training Services

Beta (adjusted)1.15

Intrinsic Value $12.48median of 6 methods · middle span $10-$20based on filings through 30 Jun 2026

Market Price $18.67Price as of 30 Sep 2026

OvervaluedIntrinsic value is 33% below the market price

−50% · IV below pricenear fair value ±15%IV above price · +50%

Data confidence Sign in to view data confidence

Market Cap $1B

Enterprise Value $1.1B

Shares Outstanding 55.9M diluted

Moat Rating None

Next Earnings Date18 Nov 2026

Last ex-dividend17 Mar 2016

All prices and values are periodic snapshots, not live quotes. Source dates are shown for reference.

Thesis

Street consensus, scenarios, merits, risks, and invalidation triggers

AI-assisted

Thesis Summary

Universal Technical Institute (UTI) is executing an aggressive expansion roadmap under its 'North Star Strategy Phase II,' aiming to open 12 to 16 new campuses and launch 50 to 70 new programs by fiscal 2029. While front-loaded growth investments of approximately $40 million are compressing near-term fiscal 2026 net income, the company's core enrollment metrics remain highly robust. Average full-time active students grew 7.2% in the most recent quarter, and the lifting of growth restrictions on Concorde Career Colleges provides a clear runway for accelerated healthcare program rollouts. UTI's strong alignment with structural labor market deficits in skilled trades and healthcare positions the company for substantial long-term earnings power and high return on invested capital (ROIC) as new campuses mature.

This section is the 12-month view: analyst targets and the probability-weighted scenarios built from them. The intrinsic value at the top of this page answers a different question: what the business is worth today.

Street view · analyst 12-month targets6 analysts · as of 18 Aug 2026

Low · most bearish analyst$37.00

Mean target$41.83

High · most bullish analyst$48.00

Street targets sit above today's price; our intrinsic value sits below it. Different horizons, different questions.

Our research · scenarios, merits, risks, and invalidation triggersResearch as of 18 Sep 2026

Scenarios · 12-month scenario targetsAnchored at research date

Bear CaseDownside scenario

$37.00

Front-loaded expansion costs and operational delays in campus openings lead to prolonged margin compression. Additionally, potential regulatory headwinds from the U.S. Department of Education regarding financial aid eligibility or borrower defense rules restrict student acquisition and increase compliance costs, dampening long-term growth expectations.

Base CaseCentral scenario

$41.83

Matches the consensus mean

UTI successfully delivers on its fiscal 2026 guidance of $905 million to $915 million in revenue and adjusted EBITDA of $114 million to $119 million. The company continues its steady rollout of new campuses in key metro areas like Atlanta and San Antonio, with student starts meeting the projected 31,500 to 33,000 range, justifying a valuation close to the consensus analyst target.

Bull CaseUpside scenario

$48.00

Accelerated student enrollment and rapid maturation of new campuses drive revenue and EBITDA well above management's long-term targets. The Concorde healthcare segment experiences high-yield program launches, and strong pricing power offsets inflationary instructional costs, leading to rapid margin expansion and ROIC exceeding 30% on new locations.

Scenarios are anchored to street consensus at the research date, with our probabilities and rationale.

Key Investment Merits

Strong organic enrollment growth with average full-time active students up 7.2% year-over-year.
Lifting of regulatory growth restrictions on Concorde Career Colleges, enabling accelerated healthcare program expansions.
Robust structural demand for skilled trades and healthcare professionals, supported by long-term BLS labor projections.
High projected return on invested capital (ROIC) exceeding 30% for mature campuses and over 65% for individual programs.

Key Investment Risks

Near-term margin compression and earnings decline due to $40 million in front-loaded strategic growth investments.
Regulatory risks associated with Title IV funding, borrower defense regulations, and Department of Education compliance.
Execution risks in scaling the campus footprint from 34 current locations under the North Star Strategy Phase II.

Thesis Invalidation Triggers

A significant drop in new student starts below the guided 31,500 range for fiscal 2026.
Failure of newly launched campuses to reach the targeted 700 to 1,500 student enrollment levels within planned timeframes.
Adverse regulatory changes that restrict access to federal student aid or impose severe compliance penalties.

All scenarios are estimates and subject to change. Past performance is not indicative of future results.

Quality Pillars Members

This section is available to registered members. Create a free account or sign in to unlock the full breakdown.

Explore this dossier

ValuationIntrinsic value, the six-method breakdown, peer medians, and your assumptions sandbox.Financial SnapshotRevenue, profitability, returns, balance sheet, dividends, and the filing-level detail.Qualitative AnalysisBusiness overview, strategic initiatives, and mergers, acquisitions & partnerships.Outlook & Key DatesForward estimates, reporting calendar, and the monitoring framework.